clinical trial · NCT05217537
Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections
Bacterial InfectionsOmadacycline Injection [Nuzyra]Omadacycline Oral Tablet
brief summary
The purpose of this study is to evaluate the pharmacokinetics of a single dose of intravenous or oral omadacycline in children and adolescents with suspected or confirmed bacterial infections.
started
Apr 6, 2022
primary completion
Feb 27, 2025
completion
Feb 27, 2025
last updated
Mar 9, 2026
official title
A Phase 1, Open-Label, Multi-Center Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Intravenous and Oral Doses of Omadacycline in Pediatric Subjects With Suspected or Confirmed Bacterial Infections
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol